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Neuronal Nicotinic Acetylcholine Receptors: The Development of Methods
for Producing Affinity-Purified and Lipid-Reconstituted Receptors that
Retain Functionality
Akash Pandhare, Steven Riela, Michaela Jansen, Michael P. Blanton.
Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Neuronal nicotinic acetylcholine receptors (nAChRs) are allosteric proteins
which belong to the Cys-loop superfamily of pentameric ligand-gated ion
channels. Many therapeutically relevant drugs act as positive/negative allo-
steric modulators of these receptors and are sensitive/selective to the confor-
mational state of the receptor. Studies to identify the molecular interactions
of an agent with a particular neuronal nAChR via a technique such as photo-
affinity labeling require purified receptors that retain the ability to undergo
conformational transitions between functional states. However, producing pu-
rified neuronal nAChRs that are fully functional has proven to be a challenge
(see Ref 1-2). With the present study we are systematically assessing the
functionality of neuronal nAChRs at different critical steps during isolation
(membrane isolation, detergent solubilization, lipid reconstitution, etc).
Each step is optimized with respect to both increasing the yield of protein,
but importantly also to ascertain functionality. Pre-assembled nAChRs are
microinjected into oocytes, a method pioneered by the Miledi group (3),
and following fusion of receptors with the oocyte plasma-membrane, two-
electrode voltage-clamp recordings are used to monitor receptor
functionality.
[1] Hamouda et al (2007) Biochemistry 46(48), 13837-46.
[2] daCosta et al (2011) Biochem Biophys Res Commun 407(3), 456-60.
[3] Marsal et al (1995) PNAS 92, 5224-28.
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Clinic, Rochester, MN, USA.
Neuronal a7 nicotinic receptors elicit rapid calcium influx in response to
acetylcholine (ACh) or its product choline. They contribute to cognition, syn-
aptic plasticity, and neuroprotection, and have been implicated in neurodegen-
erative and neuropsychiatric disorders. a7, however, often localizes distal to
sites of nerve-released ACh, binds ACh with low affinity, and thus elicits
its biological response with low agonist occupancy. To assess function of
a7 when neurotransmitter occupies fewer than five of its identical binding
sites, we measured open-channel lifetime of individual receptors in which
four of the five ACh binding-sites were disabled. We find that in receptors
with only one intact binding site, open-channel lifetime is indistinguishable
from receptors with five intact binding sites, counter to expectations from pro-
totypical neurotransmitter-gated ion channels where open-channel lifetime in-
creases with the number of binding sites occupied by agonist. The
replacement of the membrane-embedded domain of a7 by that of the related
5-HT3A receptor changes the dependence of open-channel stability on ACh
occupancy, thus revealing a novel interdependence between the detector
and actuator domains of these receptors. The distinctive ability of a single oc-
cupancy to elicit a full biological response adapts a7 to volume transmission,
a prevalent mechanism of ACh-mediated signaling in the nervous system and
non-neuronal cells.
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Nicotinic acetylcholine receptors (nAChRs) are transmembrane receptors,
members of the ligand-gated ion channels (LGIC) family, and key compo-
nent of the neuromuscular junction. On vertebrate they mediate nervous im-
pulse supporting the synaptic mechanism. As a result the nAChR are
important targets for the treatment of neurodegenerative diseases such as
Alzheimer’s, Parkinson’s, epilepsy, and schizophrenia (Albequerque et al.
2009)., as well as cardiovascular disease, inflammation (Wang et al 2003),
depression, and nicotine addiction. On the past four decades the nAChR
have being extensively study, however the relation between detergent solu-
bilization and nAChR stability is still poorly understood. Our work con-
siders the detergent structural features and physical properties to classifythe detergents into cholesterol-analogs and phospholipid-analogs; which
will be employed to isolates nAChR from Torpedo californica’s electroplax
tissue. The present study attempt to better understand how detergent solubi-
lization affects the nAChR stability once inserted to the Lipidic Cubic Phase
(LCP). We examined the Fractional Mobility (FM) of the nAChR on the
LCP through fluorescence recovery after photo bleaching (FRAP) experi-
ments for a 30 days period. Our results show that phospholipid-analog de-
tergents with 16 carbon acyl chains sustain nAChR mobility unchanged for
the 30 day period, while in most of cholesterol-analog detergents, the
nAChR moility decays on the first 15 to 20 days of the experiment. In addi-
tion there is an interesting correlation between the elongation of the acyl
chain on phospholipid-analog detergents and an increment on the FM,
particularly observed on the Lyso-Foscholine detergent family. This work
is supported by NIH Grant 1R01GM098343-01. Luis F. Padilla-Morales
and Joel E. Gonza´lez Nieves equally contribute to this work and both
will be presenters.
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Cholesterol has been shown to play a critical role in the function of ion chan-
nels and many types of ion channels partition into cholesterol-rich mem-
branes. Several Eukaryotic pentameric ligand-gated ion channels, including
the nicotinic Acetylcholine Receptor and the GABA(A) receptor, are highly
sensitive to the cholesterol content of reconstitution mixtures or native mem-
branes, but the binding interactions between cholesterol and these receptors
are largely uncharacterized. Since the mechanisms for modulation by choles-
terol are likely to be at least partially through direct interactions via specific
binding, cholesterol molecules may form an essential component of the native
structure for some of these receptors. We recently proposed, based on the
crystal structure of the glutamate-gated chloride channel (GluCl) from C. el-
egans solved in complex with the lipophilic ligand ivermectin, that cholesterol
molecules could bind to these intersubunit sites in a pose analogous to that of
ivermectin in the absence of other modulators, and tested this model in the
homologous GABA(A) receptor using Molecular Dynamics Simulations.
Here we employ computational free energy calculation methods to provide
a quantitative estimate of the binding affinity of cholesterol for these sites
on GluCl and other pentameric ligand-gated ion channels, demonstrating
that these sites are likely to be occupied at sufficiently high concentrations
of cholesterol.
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Nicotinic acetylcholine a7 receptors (nAChRa7) have been implicated in
certain pathological conditions associated with memory impairment, including
schizophrenia and Alzheimer’s disease. In vivo experiments have shown that
both nAChRa7 agonist and nAChRa7 positive allosteric modulators (PAMs)
can improve cognition in various preclinical models. Following these results
there has been a lot of interest in developing new nAChRa7 ligands for the po-
tential use for cognition in both schizophrenia and Alzheimer’s disease. The
use of new nAChRa7 compounds in schizophrenia would probably be add-
on to existing antipsychotics. Therefore it is important to investigate if antipsy-
chotic compounds have any effects on the positive effects of new nAChRa7
compounds. We have previously shown that antipsychotic compounds are in-
hibitors of ACh induced responses at h-a7 receptors with IC50 values between
2100 and 6500 nM. In this study we have further evaluated the effects of anti-
psychotic compounds on the agonistic response at h-a7 receptors induced by
nAChRa7 agonists i.e. EVP-6124 (EVP) and TC-5619 (TC). All tested antipsy-
chotics compounds showed inhibition of the agonistic response induced by both
EVP and TC at h-a7 receptors with the following IC50 values in nM for EVP
and TC, respectively: haloperidol (2400, 1900), clozapine (1800, 2700), olan-
zapine (3000, 2000), quetiapine (3200, 3000), aripiprazole (2300, 1900) and
risperidone (2000, 1500). These IC50 values are higher than the clinically
plasma concentrations for antipsychotics drugs in stabile out patients. In sum-
mary, it was shown that antipsychotic compounds antagonize both EVP-6124
and TC-5619 induced agonistic response at nAChRa7 receptors with IC50
values between 1500 and 3200 nM.
